PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

To be able to take part in this study, you generally need to be an adult between 18 and 80 years old. You must have a confirmed diagnosis of certain types of scarring lung disease that are *not* called Idiopathic Pulmonary Fibrosis (IPF). These specific types often include lung conditions linked to autoimmune diseases (like rheumatoid arthritis or lupus) or scar tissue related to certain environmental allergies.

There are also some important reasons why you might *not* be able to join. For example, if your initial diagnosis of lung scarring was more than five years ago, or if your lung condition is very mild with little scarring. You also couldn't take part if you have extensive emphysema (another type of lung damage), or if you've had certain types of cancer recently. You also can't be pregnant or planning to become pregnant, or be taking specific medications for lung fibrosis that are part of other clinical trials.

If you decide to join this study, you would be followed for two years. This is an 'observational' study, meaning you wouldn't be given any new or experimental medicines as part of the research. Instead, the doctors will simply observe your condition and collect information as you go about your usual medical care.

Your participation would involve regular visits where doctors would collect detailed information about your health. This includes taking blood and other bodily fluid samples, and having special lung tests and scans. These assessments would happen at specific times throughout the two-year period. The study team would explain the exact schedule of visits and what happens at each one.